Treating Phobia by a New Emotional Regulation Method (Tipi) (RE)

Treating Phobias Using Emotional Regulation Developed by the Tipi Association

• Background In emotional regulation, the patient remembers an emotional situation, focuses his attention on his physical sensations when he relives a recent emotion, and let evolve his sensations.
• Method Evaluate the relevance of this method by an interventional study, in a pre-post mono group, on patients suffering from phobia.
• Objective The investigators aim to validate the effectiveness of this emotional regulation method and compare its results with that of conventional methods. Sessions are individual and repeated until the disappearance of phobic fear.

The present study may contribute to propose a new possibility to treat phobias in a simple and fast way.

Study Overview

• Status: Completed
• Conditions: Phobic Fear

Detailed Description

Between 2003 and 2006, the investigators conducted an exploratory, prospective and comparative research study, taking each person as their own control, to evaluate the benefits of the type of emotional regulation developed by the Tipi association on a population suffering from phobias.

- Participants Phobias can be categorized by type, as defined in the DSM IV, the standard reference during the study period (American Psychiatriy Association, 2000) : agoraphobias, social phobias, specific situational phobias (claustrophobia, transport phobia), phobias linked to the natural environment (heights, water, fire), to animals (spiders, snakes, amphibians, tentacled shellfish) and other types of specific phobias (fear of physical contact, being dirtied, contaminated, vomiting), phobia of blood - injections - medical techniques - accidents.

The investigators aim to conduct a prior and systematic verification with each person to confirm that their fears were phobias as defined in the DSM IV (American Psychiatriy Association, 2000). The phobia must be diagnosed by a doctor or psychiatrist. Each people must provide a medical certificate that evidenced the diagnosis in writing.

All people must read an information form on "Understanding your emotions" All participants must have suffered from their phobias for a long time. They have to describe their treatment.

Everybody in the study population have to provide a short-written report on the effects of the session(s) 1 week, 1 month, 3 months and 12 months after the session.

• Intervention (see below)
• Follow-up During the one-year follow-up period, the patient was requested to send a written self-assessment of his situation and the change and/or disappearance of his phobia. If the investigators didn't receive the person's assessment, the investigators followed-up with a mail and a phone call.

• Study Type: Observational
• Enrollment (Actual): 170

Contacts and Locations

Study Locations

• France
  • Montpellier, France, 34295
    • UHMontpellier

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 90 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

People with a phobic fear listed in the DSM IV classification

Description

Inclusion criteria :

• Adult: 18-90 years old
• Adult People with phobic fear in the DSM IV classification
• Phobic people: agoraphobia, with or without panic associated, social phobias and specific phobias. Diagnosis of phobias must be established by the medical world during consultations and explorations. This is systematically checked with the patient to see if the fears come under a phobia as defined in the DSM IV, reference at the time in 2006 (ref DSM IV). The list of phobias classified by type is as follows: animal type or insects; natural environment type (phobias storms, height, water ...); blood type - injection - accident (phobia of seeing blood or an accident or having an injection or any other invasive medical procedure); situational type (fear of specific situations such as public transport, tunnels, bridges, elevators, air travel, driving a car or enclosed areas); another type: afraid to choke, to vomit or contract an illness, fear of falling, and fears about loud noises or disguised characters.
• People accepting regular follow-up until one year after the first session.

Exclusion criteria:

Subject unable to read or/and write

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
evolution of phobic fear	evolution of phobic fear	Assessment at 3 and 12 month after the first session

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
number of sessions needed for the disappearance of phobic fear	number of sessions needed for the disappearance of phobic fear	1 day
adverse reaction rate and description	adverse reaction rate and description	1 day
existence of physical and psychological sensations experienced during the sessions and just in the course of	existence of physical and psychological sensations experienced during the sessions and just in the course of	1 day
degree of process acceptance for the patient	degree of process acceptance for the patient	1 day

Collaborators and Investigators

• Sponsor: University Hospital, Montpellier
• Collaborators: Luc Nicon, Education Specialist, Founder of "Tipi", a non-profit French association
• Investigators: Principal Investigator: Luc Nicon, University Hospital, Montpellier

Study record dates

Study Major Dates

• Study Start (ACTUAL): January 1, 2003
• Primary Completion (ACTUAL): December 1, 2006
• Study Completion (ACTUAL): December 30, 2006

Study Registration Dates

• First Submitted: November 13, 2019
• First Submitted That Met QC Criteria: November 13, 2019
• First Posted (ACTUAL): November 18, 2019

Study Record Updates

• Last Update Posted (ACTUAL): November 19, 2019
• Last Update Submitted That Met QC Criteria: November 18, 2019
• Last Verified: November 1, 2019

More Information

Terms related to this study

• Other Study ID Numbers: RECHMPL19_0539

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: NC

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No